News

The universal oxygen carrier delivery capabilities of BXT-25 can be monitored, broadening its applications to treat hypoxic diseases - Leading drug candidate ProLectin-M targets galectins in viral ...
Increased dietary folic acid intake may lead to adverse health effects, including inflammation and neurotoxicity, ...
Parkinson’s disease is often mistaken for routine aging—but ignoring early warning signs can delay crucial treatment. For ...
Cyanide is a highly lethal chemical that has been used in warfare and poisonings for centuries—that was the general consensus on the naturally occurring chemical up until spring 2025. But in a global ...
The Michigan Court of Appeals, in effect, ruled that Chelsea Hospital and the drugmaker, Gilead Sciences Inc., are immune ...
Sepsis misdiagnosis was associated with delayed antibiotic therapy but not in-hospital mortality, and high-risk groups were more prone to over rather than underdiagnosis.
and hypoxia. The company’s three core platform technologies—glycovirology, cancer metastasis, and oxygen delivery—underpin its innovative pipeline. In addition to ProLectin-M, Bioxytran is advancing ...
Acute ischemic stroke disrupts communication between neurons and blood ... In conclusion, we discovered the vital role of neuronal CircOGDH under hypoxia in influencing ECs through sEVs, crucial for ...
Certain health conditions reduce the quality of your sleep. But there's a particular sleep disorder that puts your ...